ID

41804

Description

Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS); ODM derived from: https://clinicaltrials.gov/show/NCT00986960

Lien

https://clinicaltrials.gov/show/NCT00986960

Mots-clés

Versions (3)
  1. 21/01/2021 21/01/2021 - Ahmed Rafee, MD
  2. 22/01/2021 22/01/2021 - Ahmed Rafee, MD
  3. 22/01/2021 22/01/2021 - Sarah Riepenhausen
Détendeur de droits

University at Buffalo

Téléchargé le

21 janvier 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Multiple Sclerosis NCT00986960

Anglais

Eligibility Multiple Sclerosis NCT00986960

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient diagnosed with ms according to mcdonald criteria
Description

patient diagnosed with ms according to mcdonald criteria

Type de données

boolean

Alias
UMLS CUI [1,1]
C0026769
UMLS CUI [1,2]
C0679228
age 18-65
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
have a rr disease course
Description

have a rr disease course

Type de données

boolean

Alias
UMLS CUI [1,1]
C3808177
UMLS CUI [1,2]
C0026769
have edss scores 0-5.5
Description

have edss scores 0-5.5

Type de données

boolean

Alias
UMLS CUI [1]
C0451246
have a disease duration <20 years
Description

have a disease duration <20 years

Type de données

boolean

Alias
UMLS CUI [1,1]
C0872146
UMLS CUI [1,2]
C0026769
sub-optimal response to interferon beta-1a i.m. (avonex®) while being on therapy for at least 6 months defined as: presence of a documented relapse within the last 12 months OR the presence of at least one enhancing T1 Gd lesion on an MRI performed within previous 3 months
Description

sub-optimal response to interferon beta-1a i.m. (avonex®) while being on therapy for at least 6 months defined as: presence of a documented relapse within the last 12 months OR the presence of at least one enhancing T1 Gd lesion on an MRI performed within previous 3 months

Type de données

boolean

Alias
UMLS CUI [1,1]
C0254119
UMLS CUI [1,2]
C0021492
UMLS CUI [1,3]
C2984009
UMLS CUI [1,4]
C0521982
UMLS CUI [1,5]
C0026769
UMLS CUI [1,6]
C0444921
UMLS CUI [2,1]
C0035020
UMLS CUI [2,2]
C0026769
UMLS CUI [2,3]
C0332185
UMLS CUI [2,4]
C1301725
UMLS CUI [3,1]
C1333400
UMLS CUI [3,2]
C0449788
signed informed consent
Description

signed informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
normal kidney functioning (creatinine clearance >59)
Description

normal kidney functioning (creatinine clearance >59)

Type de données

boolean

Alias
UMLS CUI [1]
C0373595
none of the exclusion criteria
Description

none of the exclusion criteria

Type de données

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C0444868
UMLS CUI [1,3]
C0332197
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
presence of relapse or steroid treatment within 60 days prior to study enrollment
Description

presence of relapse or steroid treatment within 60 days prior to study enrollment

Type de données

boolean

Alias
UMLS CUI [1,1]
C0026769
UMLS CUI [1,2]
C0035020
UMLS CUI [1,3]
C0332185
UMLS CUI [2,1]
C0149783
UMLS CUI [2,2]
C0332185
presence of neutralizing antibodies to ifnβ-1a i.m. prior to study enrollment
Description

presence of neutralizing antibodies to ifnβ-1a i.m. prior to study enrollment

Type de données

boolean

Alias
UMLS CUI [1,1]
C1997641
UMLS CUI [1,2]
C0332185
presence of optic neuritis within less than 6 months prior to study enrollment
Description

presence of optic neuritis within less than 6 months prior to study enrollment

Type de données

boolean

Alias
UMLS CUI [1,1]
C0029134
UMLS CUI [1,2]
C0332185
diagnosis of osteoporosis (t score ≥2.5 sd)
Description

diagnosis of osteoporosis (t score ≥2.5 sd)

Type de données

boolean

Alias
UMLS CUI [1,1]
C0029456
UMLS CUI [1,2]
C3854607
women who are pregnant, lactating or of childbearing age who do not consent to approved contraceptive use during the study.
Description

women who are pregnant, lactating or of childbearing age who do not consent to approved contraceptive use during the study.

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0700589
UMLS CUI [3,3]
C0558080
abnormal blood tests, performed during the screening visit including: hepatitis b or hepatitis c, alt or ast greater than two times the upper limit of normal, abnormal glucose fasting levels or already known diabetes
Description

abnormal blood tests, performed during the screening visit including: hepatitis b or hepatitis c, alt or ast greater than two times the upper limit of normal, abnormal glucose fasting levels or already known diabetes

Type de données

boolean

Alias
UMLS CUI [1,1]
C0008000
UMLS CUI [1,2]
C0205161
UMLS CUI [1,3]
C1710032
UMLS CUI [2,1]
C0744837
UMLS CUI [2,2]
C0205161
UMLS CUI [3,1]
C0850489
UMLS CUI [3,2]
C0205161
UMLS CUI [4,1]
C0201836
UMLS CUI [4,2]
C0205161
UMLS CUI [5,1]
C0201899
UMLS CUI [5,2]
C0205161
UMLS CUI [6,1]
C0583513
UMLS CUI [6,2]
C0205161
UMLS CUI [7]
C0011849
history of depression while on ifnβ-1a i.m.
Description

history of depression while on ifnβ-1a i.m.

Type de données

boolean

Alias
UMLS CUI [1,1]
C0205156
UMLS CUI [1,2]
C0262926
UMLS CUI [1,3]
C0041755
UMLS CUI [1,4]
C0254119
Retour au début de la page

Similar models

Eligibility Multiple Sclerosis NCT00986960

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
patient diagnosed with ms according to mcdonald criteria
Item
patient diagnosed with ms according to mcdonald criteria
boolean
C0026769 (UMLS CUI [1,1])
C0679228 (UMLS CUI [1,2])
Age
Item
age 18-65
boolean
C0001779 (UMLS CUI [1])
have a rr disease course
Item
have a rr disease course
boolean
C3808177 (UMLS CUI [1,1])
C0026769 (UMLS CUI [1,2])
have edss scores 0-5.5
Item
have edss scores 0-5.5
boolean
C0451246 (UMLS CUI [1])
have a disease duration <20 years
Item
have a disease duration <20 years
boolean
C0872146 (UMLS CUI [1,1])
C0026769 (UMLS CUI [1,2])
sub-optimal response to interferon beta-1a i.m. (avonex®) while being on therapy for at least 6 months defined as: presence of a documented relapse within the last 12 months OR the presence of at least one enhancing T1 Gd lesion on an MRI performed within previous 3 months
Item
sub-optimal response to interferon beta-1a i.m. (avonex®) while being on therapy for at least 6 months defined as: presence of a documented relapse within the last 12 months OR the presence of at least one enhancing T1 Gd lesion on an MRI performed within previous 3 months
boolean
C0254119 (UMLS CUI [1,1])
C0021492 (UMLS CUI [1,2])
C2984009 (UMLS CUI [1,3])
C0521982 (UMLS CUI [1,4])
C0026769 (UMLS CUI [1,5])
C0444921 (UMLS CUI [1,6])
C0035020 (UMLS CUI [2,1])
C0026769 (UMLS CUI [2,2])
C0332185 (UMLS CUI [2,3])
C1301725 (UMLS CUI [2,4])
C1333400 (UMLS CUI [3,1])
C0449788 (UMLS CUI [3,2])
signed informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
normal kidney functioning (creatinine clearance >59)
Item
normal kidney functioning (creatinine clearance >59)
boolean
C0373595 (UMLS CUI [1])
none of the exclusion criteria
Item
none of the exclusion criteria
boolean
C0680251 (UMLS CUI [1,1])
C0444868 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
presence of relapse or steroid treatment within 60 days prior to study enrollment
Item
presence of relapse or steroid treatment within 60 days prior to study enrollment
boolean
C0026769 (UMLS CUI [1,1])
C0035020 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0149783 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
presence of neutralizing antibodies to ifnβ-1a i.m. prior to study enrollment
Item
presence of neutralizing antibodies to ifnβ-1a i.m. prior to study enrollment
boolean
C1997641 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
presence of optic neuritis within less than 6 months prior to study enrollment
Item
presence of optic neuritis within less than 6 months prior to study enrollment
boolean
C0029134 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
diagnosis of osteoporosis (t score ≥2.5 sd)
Item
diagnosis of osteoporosis (t score ≥2.5 sd)
boolean
C0029456 (UMLS CUI [1,1])
C3854607 (UMLS CUI [1,2])
women who are pregnant, lactating or of childbearing age who do not consent to approved contraceptive use during the study.
Item
women who are pregnant, lactating or of childbearing age who do not consent to approved contraceptive use during the study.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0558080 (UMLS CUI [3,3])
abnormal blood tests, performed during the screening visit including: hepatitis b or hepatitis c, alt or ast greater than two times the upper limit of normal, abnormal glucose fasting levels or already known diabetes
Item
abnormal blood tests, performed during the screening visit including: hepatitis b or hepatitis c, alt or ast greater than two times the upper limit of normal, abnormal glucose fasting levels or already known diabetes
boolean
C0008000 (UMLS CUI [1,1])
C0205161 (UMLS CUI [1,2])
C1710032 (UMLS CUI [1,3])
C0744837 (UMLS CUI [2,1])
C0205161 (UMLS CUI [2,2])
C0850489 (UMLS CUI [3,1])
C0205161 (UMLS CUI [3,2])
C0201836 (UMLS CUI [4,1])
C0205161 (UMLS CUI [4,2])
C0201899 (UMLS CUI [5,1])
C0205161 (UMLS CUI [5,2])
C0583513 (UMLS CUI [6,1])
C0205161 (UMLS CUI [6,2])
C0011849 (UMLS CUI [7])
history of depression while on ifnβ-1a i.m.
Item
history of depression while on ifnβ-1a i.m.
boolean
C0205156 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C0041755 (UMLS CUI [1,3])
C0254119 (UMLS CUI [1,4])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial